tiprankstipranks
Celyad Oncology (CYADY)
OTHER OTC:CYADY

Celyad Oncology (CYADY) Technical Analysis

408 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Celyad Oncology’s (CYADY) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Celyad Oncology is a Buy.
Celyad Oncology’s (CYADY) 20-Day exponential moving average is 0.72, while Celyad Oncology’s (CYADY) share price is $0.6, making it a Sell.
Celyad Oncology’s (CYADY) 50-Day exponential moving average is 0.72, while Celyad Oncology’s (CYADY) share price is $0.6, making it a Sell.

Celyad Oncology (CYADY) Pivot Points

May 02, 2024, 02:19 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.68
0.68
0.68
0.68
0.68
0.68
0.68
Fibonacci
0.68
0.68
0.68
0.68
0.68
0.68
0.68
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Celyad Oncology (CYADY) Moving Averages

May 02, 2024, 02:19 AM
Period
Simple
Exponential
MA5
0.69Sell
0.68Sell
MA10
0.72Sell
0.70Sell
MA20
0.73Sell
0.72Sell
MA50
0.74Sell
0.72Sell
MA100
0.66Sell
0.71Sell
MA200
0.81Sell
0.81Sell
Celyad Oncology’s (CYADY) 10-Day exponential moving average is 0.70, while Celyad Oncology’s (CYADY) share price is $0.6, making it a Sell.
Celyad Oncology’s (CYADY) 100-Day exponential moving average is 0.71, while Celyad Oncology’s (CYADY) share price is $0.6, making it a Sell.
Celyad Oncology’s (CYADY) stock price is $0.6 and Celyad Oncology’s (CYADY) 50-day simple moving average is 0.74, creating a Sell signal.
Celyad Oncology’s (CYADY) stock price is $0.6 and Celyad Oncology’s (CYADY) 100-day simple moving average is 0.66, creating a Sell signal.
Celyad Oncology’s (CYADY) stock price is $0.6 and Celyad Oncology’s (CYADY) 200-day simple moving average is 0.81, creating a Sell signal.

Celyad Oncology (CYADY) Technical Indicators

May 02, 2024, 02:19 AM
Name
Value
Implied Action
RSI (14)
41.60
Neutral
STOCH (9,6)
0.11
Buy
STOCHRSI (14)
0.26
Buy
MACD (12,26)
-0.02
Buy
ADX (14)
8.50
Buy
Williams %R
-96.97
Buy
CCI (14)
-126.09
Buy
ATR (14)
0.04
-
Ultimate Oscillator
23.31
Sell
ROC
-21.95
Sell
Celyad Oncology’s (CYADY) Relative Strength Index (RSI) is 41.60, creating a Neutral signal.
Celyad Oncology’s (CYADY) Trend Strength Indicator (ADX) is 8.50, creating a Buy signal.
Celyad Oncology’s (CYADY) Commodity Channel Index (CCI) is -126.09, creating a Buy signal.
Celyad Oncology’s (CYADY) Price Rate of Change (ROC) is -21.95, creating a Sell signal.

FAQ

Is CYADY a Buy, Hold, or Sell?
Based on CYADY’s technical indicators, CYADY is a Sell.
    What is CYADY’s RSI (14)?
    CYADY’s RSI (14) is 41.60, which suggests CYADY is a Neutral.
      What is CYADY’s MACD?
      CYADY’s MACD is -0.02, which suggests CYADY is a Buy.
        What is CYADY’s 5-day moving average?
        CYADY’s 5-day moving average is 0.69, which suggests CYADY is a Sell.
          What is CYADY’s 20-day moving average?
          CYADY 20-day moving average is 0.73, which suggests CYADY is a Sell.
            What is CYADY’s 50-day moving average?
            CYADY’s 50-day moving average is 0.74, which suggests CYADY is a Sell.
              What is CYADY’s 200-day moving average?
              CYADY’s 200-day moving average is 0.81, which suggests CYADY is a Sell.
                What is CYADY’s Williams % R (14)?
                CYADY’s Williams % R (14) is -96.97, which suggests CYADY is a Buy.
                  What is CYADY’s CCI (14)?
                  CYADY’s CCI (14) is -126.09, which suggests CYADY is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis